Chúng ta hiện đang sông trong bối cảnh giao thoa giữa con người-mầm bệnh-động vật và môi trường xung quanh, do vậy có thể một ai đó không biết nếu mầm bệnh có thể tấn công bất cữ lúc nào và gây nên bệnh Melioidosis. Trung tâm CDC và các cơ quan đại diện liên bang khác đang quan tâm đến các cuộc tấn công sinh học (biological attacks), bao gồm cả sử dụng mầm bệnh gây nên Melioidosis. Tại sao mầm bệnh gây Melioidosis có thể coi như một vũ khí sinh học? Nếu một người hay một nhóm người muốn sử dụng các mầm bệnh như một vũ khí, họ có thể dùng các mầm bệnh mà có thể gây nên bệnh Melioidosis vì chúng có thể dễ dàng tìm thấy trong tự nhiên ở một số vùng trên thé giới, hơn nữa chúng dễ dàng gây bệnh nhiễm trùng nghiêm trọng, nếu không can thiệp điều trị kháng sinh sớm, bệnh nhân có thể tử vong.

Bệnh Melioidosis có thể là một bệnh rất nghiêm trọng, tác nhân gây bệnh có thể kháng tự nhiên với nhiều loại kháng sinh nên sẽ gây khó cho vấn đề lựa chọn điều trị cho bệnh nhân. Do vậy cỉ có một kháng sính có hiệu quả. Nếu không điều trị có thể 90% dẫn đế n tử vong, ngược lại nếu điều trị kháng sinh thích hợp chỉ có 40% tử vong. Điều trị cần có sự chăm sóc tích cực để giảm tử vong đến mức thấp nhất và nếu có thể cứu lấy 90% số ca. Cần lưu ý, một số trường hợp có bệnh lý nền như đái tháo đường, bệnh phổi mạn tính, nghiện rượu, bệnh thận mạn và các bệnh lý liên quan hệ thống miễn dịch có thể dẫn đến bệnh nặng nền hơn rất nhiều.

Các bệnh nhân mắc Melioidosis cần phải nhập viện điều trị, khi đã hồi phục thì mới trở về nhà, sau khi về nhà có thể còn phải dùng đến kháng sinh trong nhiều tháng nữa. Điều tị kéo dài với mục đích làm cho kháng sinh giết chết các mầm bệnh trong cơ thể người và ngăn ngừa bệnh tái phát. Đôi khi trong thực hành lâm sàng, bệnh có thể rất khó chẩn đoán và dễ bỏ sót. Các triệu chưng của bệnh thường giống với một số bệnh nhiễm trùng thông thường như viêm phổi mắc phải bệnh viện, cúm, hay lao. Chỉ có một vài người được chẩn đoán nhiễm Melioidosis mỗi năm tại Mỹ, đối tượng đó mắc bệnh thường phơi nhiễm mầm bệnh do quá trình họ đi du lịch đến một quốc gia nào đó mắc từ nguồn tự nhiên. Vì có một vài người ơt Mỹ mắc bệnh mà hầu hết các bác sỹ không nghĩ cũng như không làm quen với bệnh nên có thể làm chậm tiến độ chẩn đoán và điều trị.

Tấn công sinh học tiết ra các mầm bệnh trong đó có bệnh Melioidosis có mặt trong không khí, nước và thực phẩm nên sẽ có nguy cơ nhiều đối tượng nhiễm bệnh. Chẳng hạn, nếu các mầm bệnh đào thải vào trong không khí, đặc biệt những nơi đông đúc và nhiều người có thể hít phải mầm bệnh. Nếu mầm bệnh trong thức ăn, con người ăn phải các thực phẩm nhiễm cũng có thể nhiễm bệnh. Bất cứ một người nào phơi nhiễm với mầm bệnh thì đều nguy hiểm và dễ nhiễm bệnh.

Bạn có thể không nhìn thấy, không biết mùi hay vị của mầm bệnh, vì thế đối tượng không biết dể tránh xa. Tấn công của mầm bệnh không được lưu ý mãi cho đến khi các bác sỹ gặp bệnh nhân có sốt và biểu hiện các triệu chứng hô hấp. Một khi các bác sỹ chẩn đoán bệnh nhân mắc melioidosis, họ sẽ làm việc với các cơ quan chức năng y tế để xem xét làm thế nào bệnh nhân mắc mầm bệnh này. Melioidosis là bệnh lý nhiễm trùng xảy ra tự nhiễn ở một số nơi một cách tự nhiên trên toàn cầu như Đông Nam Á và phía bắc Úc. Chỉ những nơi có mầm bệnh Burkholderia pseudomallei xảy ra trong tự nhiên ở Mỹ là Puerto Rico. Thường người Mỹ (ngoài Puerto Rico) mắc bệnh đã cso tiến sử du lịch và phơi nhiễm mầm bệnh ở các vùng trong tự nhiên. Một trong những lý do mà các cơ quan chức năng quan tâm đến bệnh này vì chung có trong tự nhiên dễ phơi nhiễm và gây bệnh Melioidosis có thể sử dụng như tấn công sinh học. Các tấn công sinh học do ly giải mầm bệnh có thể gây bệnh hoặc dẫn đến tử vong cho con người, gia súc và vụ mùa.

Nhằm giúp cho các đồng nghiệp và bạn đọc quan tâm căn bệnh nhiễm trùng nguy hiểm này, chúng tôi xin chia sẻ các công trình nghiên cứu trong thời gian gần đây:

1.Stanton AT, Fletcher W (1921). "Melioidosis, a new disease of the tropics". Far Eastern Association of Tropical Medicine: Transactions of the Fourth Congress. Batavia, Dutch East Indies: Javasche Boekhandel en Drukkerij.

2.A J Simpson; Suputtamongkol Y; Smith MD; et al. (1999). "Comparison of imipenem and ceftazidime as therapy for severe melioidosis". Clinical Infectious Diseases. 29 (2): 381–387. doi:10.1086/520219. PMID 10476746.

3.Ngauy V, Lemeshev Y, Sadkowski L, Crawford G (2005). "Cutaneous Melioidosis in a Man Who Was Taken as a Prisoner of War by the Japanese during World War II". Journal of Clinical Microbiology Microb. 43 (2): 970–972. doi:10.1128/JCM.43.2.970-972.2005. PMC 548040  . PMID 15695721.

4.Centers for Disease Control and Prevention. Melioidosis. 2012. Accessed February 27, 2017.

5.Apisarnthanarak A, Apisarnthanarak P, Mundy LM (2006). "Computer tomography characteristics of Burkholderia pseudomallei liver abscess". Clinical Infectious Diseases. 42 (7): 989–993. doi:10.1086/501017. PMID 16511765.

6.Laopaiboon V, Chamadol N, Buttham H, Sukeepaisarnjareon W (2009). "CT findings of liver and splenic abscesses in melioidosis: comparison with those in non-melioidosis". Journal of the Medical Association of Thailand. 92 (11): 1476–1484. PMID 19938740.

7.Dance DA, Davis TM, Wattanagoon Y, et al. (1989). "Acute suppurative parotitis caused by Pseudomonas pseudomallei in children". Journal of Infectious Diseases. 159 (4): 654-660. doi:10.1093/infdis/159.4.654. PMID 2926159.

8.Raja, NS; Ahmed MZ; Singh NN (1 April 2005). "Melioidosis: an emerging infectious disease". Journal of Postgraduate Medicine. 51 (2): 140–145. PMID 16006713.

9.Chlebicki, MP; Tan BH (2006). "Six cases of suppurative lymphadenitis caused by Burkholderia pseudomallei infection". Transactions of the Royal Society of Tropical Medicine and Hygiene. 100 (8): 798–801. doi:10.1016/j.trstmh.2005.10.004. PMID 16542691.

10.Currie BJ, Fisher DA, Howard DM, et al. (2000). "Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature". Clinical Infectious Diseases. 31 (4): 981–986. doi:10.1086/318116. PMID 11049780.

11.Falade OO, Antonarakis ES, Kaul DR, Saint S, Murphy PA (2008). "Clinical problem-solving. Beware of first impressions". New England Journal of Medicine. 359 (6): 628–634. doi:10.1056/NEJMcps0708803. PMID 18687644.

12.Chetchotisakd, P; Anunnatsiri, S; Kiatchoosakun, S; Kularbkaew, C (2010). "Melioidosis pericarditis mimicking tuberculous pericarditis". Clinical Infectious Diseases. 51 (5): e46–49. doi:10.1086/655699. PMID 20645861.

13.Suntornsut P, Kasemsupat K, Silairatana S, et al. (2013). "Prevalence of Melioidosis in Patients with Suspected Pulmonary Tuberculosis and Sputum Smear Negative for Acid-Fast Bacilli in Northeast Thailand". American Journal of Tropical Medicine and Hygiene. 89 (5): 983–985. doi:10.4269/ajtmh.13-0286. PMC 3820347  . PMID 24062474.

14.Ngauy V, Lemeshev Y, Sadkowski L, Crawford G (2005). "Cutaneous Melioidosis in a Man Who Was Taken as a Prisoner of War by the Japanese during World War II". Journal of Clinical Microbiology. 43 (2): 970–972. doi:10.1128/JCM.43.2.970-972.2005. PMC 548040  . PMID 15695721.

15.Wuthiekanun V, Suputtamongkol Y, Simpson AJ, Kanaphun P, White NJ (2001). "Value of Throat Swab in Diagnosis of Melioidosis". Journal of Clinical Microbiology. 39 (10): 3801–3802. doi:10.1128/JCM.39.10.3801-3802.2001. PMC 88440  . PMID 11574624.

16.Limmathurotsakul D, Wuthiekanun V, Chierakul W, et al. (2005). "Role and Significance of Quantitative Urine Cultures in Diagnosis of Melioidosis". Journal of Clinical Microbiology. 43 (5): 2274–2276. doi:10.1128/JCM.43.5.2274-2276.2005. PMC 1153798  . PMID 15872255.

17.Dance DA, White NJ, Suputtamongkol Y, Wattanagoon Y, Wuthiekanun V, Chaowagul W (1990). "The use of bone marrow culture for the diagnosis of melioidosis". Transactions of the Royal Society of Tropical Medicine and Hygiene. 84 (4): 585–587. doi:10.1016/0035-9203(90)90050-O. PMID 2091358.

18.Peacock SJ, Chieng G, Cheng AC, et al. (2005). "Comparison of Ashdown's Medium, Burkholderia cepacia Medium, and Burkholderia pseudomallei Selective Agar for Clinical Isolation of Burkholderia pseudomallei". Journal of Clinical Microbiology. 43 (10): 5359–5361. doi:10.1128/JCM.43.10.5359-5361.2005. PMC 1248505  . PMID 16208018.

19.Francis A, Aiyar S, Yean C, Naing L, Ravichandran M (2006). "An improved selective and differential medium for the isolation of Burkholderia pseudomallei from clinical specimens". Diagnostic Microbiology and Infectious Diseases. 55 (2): 95–99. doi:10.1016/j.diagmicrobio.2005.11.008. PMID 16626918.

20.Puthucheary SD, Anuar AS, Tee TS (2010). "Burkholderia thailandensis whole cell antigen cross-reacts with B. pseudomallei antibodies from patients with melioidosis in an immunofluorescent assay". The Southeast Asian Journal of Tropical Medicine and Public Health. 41 (2): 397-400. PMID 20578523.

21.Limmathurotsakul D, Chantratita N, Teerawattanasook N, et al. (2011). "Enzyme-Linked Immunosorbent Assay for the Diagnosis of Melioidosis: Better Than We Thought". Clinical Infectious Diseases. 52 (8): 1024–1028. doi:10.1093/cid/cir080. PMC 3070030  . PMID 21460318.

22.Peacock SJ, Cheng AC, Currie BJ, Dance DA (2011). "The Use of Positive Serological Tests as Evidence of Exposure to Burkholderia pseudomallei". American Journal of Tropical Medicine and Hygiene. 84 (6): 1021–1022. doi:10.4269/ajtmh.2011.11-0114a. PMC 3110358  . PMID 21633045.

23.Lim KS, Chong VH (2010). "Radiological manifestations of melioidosis". Clinical Radiology. 65 (1): 66–72. doi:10.1016/j.crad.2009.08.008. PMID 20103424.

24.Muttarak M, Peh WC, Euathrongchit J, Lin SE, Tan AG, Lerttumnongtum P, Sivasomboon C (2008). "Spectrum of imaging findings in melioidosis". British Journal of Radiology. 82 (978): 514–521. doi:10.1259/bjr/15785231. PMID 19098086.

25.White NJ, Dance DA, Chaowagul W, et al. (1989). "Halving of mortality of severe melioidosis by ceftazidime". Lancet. 2 (8665): 697–701. doi:10.1016/S0140-6736(89)90768-X. PMID 2570956.

26.Chierakul W, Anunnatsiri S, Chaowagul W, et al. (2007). "Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit". Clinical Infectious Diseases. 45 (4): 521–523. doi:10.1086/520010. PMID 17638209.

27.Cheng AC, Fisher DA, Anstey NM, et al. (2004). "Outcomes of Patients with Melioidosis Treated with Meropenem". Antimicrob Agents Chemother. 48 (5): 1763–65. doi:10.1128/AAC.48.5.1763-1765.2004. PMC 400582  . PMID 15105132.

28.Chetchotisakd P, Porramatikul S, Mootsikapun P, Anunnatsiri S, Thinkhamrop B (2001). "Randomized, double-blind, controlled study of cefoperazone-sulbactam plus cotrimoxazole versus ceftazidime plus cotrimoxazole for the treatment of severe melioidosis". Clinical Infectious Diseases. 33 (1): 29–33. doi:10.1086/320878. PMID 11389491.

29.Dance DA, Wuthiekanun V, White NJ, Chaowagul W (1988). "Antibiotic resistance in Pseudomonas pseudomallei". Lancet. 1 (8592): 994–995. doi:10.1016/S0140-6736(88)91810-7. PMID2896855.

30.Suputtamongkol Y, Rajchanuwong A, Chaowagul W, et al. (1994). "Ceftazidime vs. amoxicillin/clavulanate in the treatment of severe melioidosis". Clinical Infectious Diseases. 19 (5): 846–853. doi:10.1093/clinids/19.5.846. PMID 7893868.

31.University of Oxford (18 December 2007). "A randomized double blinded comparison of ceftazidime and meropenem in severe melioidosis (ATOM)". ClinicalTrials.gov. National Institutes of Health. Retrieved 27 Jan 2011.

32.Simpson, A. J. H.; Opal, S. M.; Angus, B. J.; Prins, J. M.; Palardy, J. E.; Parejo, N. A.; Chaowagul, W.; White, N. J. (2000). "Differential antibiotic-induced endotoxin release in severe melioidosis". Journal of Infectious Diseases. 181 (3): 1014–1019. doi:10.1086/315306. PMID 10720525.

33.Bilgrami, I.; Roberts, J. A.; Wallis, S. C.; Thomas, J.; Davis, J.; Fowler, S.; Goldrick, P. B.; Lipman, J. (2010). "Meropenem Dosing in Critically Ill Patients with Sepsis Receiving High-Volume Continuous Venovenous Hemofiltration". Antimicrobial Agents and Chemotherapy. 54 (7): 2974–2978. doi:10.1128/AAC.01582-09. PMC 2897321  . PMID 20479205.

34.Shih H-I; Chuang Y-C; Cheung BM-H; et al. (February 2008). "Sporadic and outbreak cases of melioidosis in southern Taiwan: clinical features and antimicrobial susceptibility". Infection. 37 (1): 9–15. doi:10.1007/s15010-008-7324-8. PMID 18854938.

35.Harris P, Engler C, Norton R (2011). "Comparative in vitro susceptibility of Burkholderia pseudomallei to doripenem, ertapenem, tigecycline and moxifloxacin". International Journal of Antimicrobia Agents. 37 (6): 547–549. doi:10.1016/j.ijantimicag.2011.02.001.

36.Thamlikitkul V, Trakulsomboon S (2010). "In vitro activity of biapenem against Burkholderia pseudomallei". International Journal of Antimicrobia Agents. 35 (5): 514. doi:10.1016/j.ijantimicag.2010.01.002. PMID 20188524.

37.Cheng AC, Limmathurotsakul D, Chierakul W, et al. (2007). "A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand". Clinical Infectious Diseases. 45 (3): 308–314. doi:10.1086/519261. PMID 17599307.

38.Chierakul W, Anunnatsiri S, Short JM, et al. (2005). "Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis". Clinicl Infectious Diseases. 41 (8): 1105–1113. doi:10.1086/444456. PMID 16163628.

39.Chierakul W, Anunnatsiri S, Chaowagul W, Peacock SJ, Chetchotisakd P, Day NP (2007). "Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a tong-term outcome benefit". Clinical Infectious Diseases. 45 (4): 521–523. doi:10.1086/520010. PMID 17638209.

40.Chaowagul W, Simpson AJ, Suputtamongkol Y, et al. (1999). "A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis". Clinical Infectious Diseases. 29 (2): 375–380. doi:10.1086/520218. PMID 10476745.

41.Rajchanuvong A, Chaowagul W, Suputtamongkol Y, Smith MD, Dance DA, White NJ (1995). "A prospective comparison of co-amoxiclav and the combination of chloramphenicol, doxycycline, and co-trimoxazole for the oral maintenance treatment of melioidosis". Transactions of the Royal Society of Tropical Medicine and Hygiene. 89 (5): 546–549. doi:10.1016/0035-9203(95)90104-3. PMID 8560537.

42.Cheng AC, Chierakul W, Chaowagul W, et al. (2008). "Short Report: Consensus Guidelines for Dosing of Amoxicillin-Clavulanate in Melioidosis". American Journal of Tropical Medicine and Hygiene. 78 (2): 208–209. PMC 3034162  . PMID 18256414.

43.Chaowagul W, Supputtamongkul Y, Smith MD, White NJ (1997). "Oral fluoroquinolones for maintenance treatment of melioidosis". Transactions of the Royal Society of Tropical Medicine and Hygiene. 91 (5): 599–601. doi:10.1016/S0035-9203(97)90044-4. PMID 9463680.

44.Chetchotisakd P, Chaowagul W, Mootsikapun P, Budhsarawong D, Thinkamrop B (Jan–Feb 2001). "Maintenance therapy of melioidosis with ciprofloxacin plus azithromycin compared with cotrimoxazole plus doxycycline". American Journal of Tropical Medicine and Hygiene. 64 (1–2): 24–27. PMID 11425157.

45.Chaowagul W,; Simpson, Andrew J. H.; Suputtamongkol, Yupin; Smith, Michael D.; Angus, Brian J.; White, Nicholas J. (August 1999). "Clin Infect Dis". Clinical Infectious Diseases. 29 (2): 375–380. doi:10.1086/520218. PMID 10476745.

46.Limmathurotsakul D; Chaowagul W; Chierakul Wirongrong; et al. (2006). "Risk factors for recurrent melioidosis in Northeastern Thailand". Clinical Infectious Diseases. 43 (8): 979–986. doi:10.1086/507632. PMID 16983608.

47.Dance DA, Wuthiekanun V, Chaowagul W, White NJ (1989). "Interactions in vitro between agents used to treat melioidosis". Journal of Antimicrobial Chemotherapy. 24 (3): 311-316. doi:10.1093/jac/24.3.311. PMID 2681117.

48.Chetchotisakd, P; Chierakul, W; Chaowagul, W; Anunnatsiri, S; Phimda, K; Mootsikapun, P; Chaisuksant, S; Pilaikul, J; Thinkhamrop, B; Phiphitaporn, S; Susaengrat, W; Toondee, C; Wongrattanacheewin, S; Wuthiekanun, V; Chantratita, N; Thaipadungpanit, J; Day, NP; Limmathurotsakul, D; Peacock, SJ (1 March 2014). "Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial". Lancet. 383 (9919): 807–814. doi:10.1016/S0140-6736(13)61951-0. PMC 3939931  . PMID 24284287.

49.Cheng AC, McBryde ES, Wuthiekanun V, Chierakul W, Amornchai P, Day NP, Peacock SJ (2009). "Dosing Regimens of Cotrimoxazole (Trimethoprim-Sulfamethoxazole) for Melioidosis". Antimicrobial Agents and Chemotherapy. 53 (10): 4193–4199. doi:10.1128/AAC.01301-08. PMC 2764189  . PMID 19620336.

50.TJ Inglis; CL Golledge; A Clair; J Harvey (2001). "Case report: recovery from persistent septicemic melioidosis". American Journal of Tropical Medicine and Hygiene. 65 (1): 76–82. PMID 11504412.

51.Dance DA, Wuthiekanun V, Chaowagul W, White NJ (1989). "Interactions in vitro between agents used to treat melioidosis". Journal of Antimicrobial Chemotherapy. 24 (3): 311–316. doi:10.1093/jac/24.3.311. PMID2681117.

52.Couture E (1935). "La Melioidosis Etat actuel de la question". Rev Hyg Méd Prèv. 57: 190.

53.Warner JM, Pelowa DB, Currie BJ, Hirst RG (2007). "Melioidosis in a rural community of Western Province, Papua New Guinea". Transactions of the Royal Society of Tropical Medicine and Hygiene. 101 (8): 809–813. doi:10.1016/j.trstmh.2007.02.024. PMID 17499321.

54.White NJ (2003). "Melioidosis". Lancet. 361 (9370): 1715–1722. doi:10.1016/S0140-6736(03)13374-0. PMID 12767750.

55.Chaowagul W, White NJ, Dance DA, et al. (1989). "Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand". Journal of Infectious Diseases. 159 (5): 890–899. doi:10.1093/infdis/159.5.890. PMID 2708842.

56.Sarovich DS, Ward L, Price EP, et al. (2014). "Recurrent melioidosis in the Darwin Prospective Melioidosis Study: improving therapies mean that relapse cases are now rare". Journal of Clinical Microbiology. 52 (2): 650–653. doi:10.1128/JCM.02239-13. PMC 3911345  . PMID 24478504.

57.Maharjan B, Chantratita N, Vesaratchavest M, et al. (2005). "Recurrent Melioidosis in Patients in Northeast Thailand Is Frequently Due to Reinfection Rather than Relapse". Journal of Clinical Microbiology. 43 (12): 6032–6034. doi:10.1128/JCM.43.12.6032-6034.2005. PMC 1317219  . PMID 16333094.

58.Chaowagul W, Suputtamongkol Y, Dance DA, Rajchanuvong A, Pattara-arechachai J, White NJ (1993). "Relapse in melioidosis: incidence and risk factors". Journal of Infectious Diseases. 168 (5): 1181–1185. doi:10.1093/infdis/168.5.1181. PMID 8228352.

59.Holland DJ, Wesley A, Drinkovic D, Currie BJ (2002). "Cystic fibrosis and Burkholderia pseudomallei infection: an emerging problem?". Clinical Infectious Diseases. 35 (12): e138–140. doi:10.1086/344447. PMID 12471591.

60.McCormick J B (1975). "Human-to-human transmission of Pseudomonas pseudomallei". Annals of Internal Medicine. 83 (4): 512–513. doi:10.7326/0003-4819-83-4-512.

61.Kunakorn M, Jayanetra P, Tanphaichitra D (1991). "Man-to-man transmission of melioidosis". Lancet. 337 (8752): 1290–1291. doi:10.1016/0140-6736(91)92962-2. PMID 1674089.

62.Centers for Disease Control and Prevention (2009). Biosafety in Microbiological and Biomedical Laboratories (5th ed.). Atlanta, Georgia: National Institutes of Health.

63.Sivalingam SP, Sim SH, Jasper LC, et al. (2008). "Pre- and post-exposure prophylaxis of experimental Burkholderia pseudomallei infection with doxycycline, amoxicillin/clavulanic acid and co-trimoxazole". Journal of Antimicrobial Chemotherapy. 61 (3): 674–678. doi:10.1093/jac/dkm527. PMID 18192684.

64.Peacock SJ, Schweizer HP, Dance DA, et al. (2008). "Management of Accidental Laboratory Exposure to Burkholderia pseudomallei and B. mallei". Emerging Infectious Diseases. 14 (7): e2. doi:10.3201/eid1407.071501. PMC 2600349  . PMID 18598617.

65.Kenny DJ, Sefton AM, Brooks TJ, Laws TR, Simpson AJ, Atkins HS (2010). "Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis for experimental murine melioidosis". International Journal of Antimicrobial Agents. 36 (1): 87–89. doi:10.1016/j.ijantimicag.2010.03.019. PMID 20462743.

66.Cheng, A. C., & Currie, B. J. (2005). Melioidosis: Epidemiology, Pathophysiology, and Management. Clinical Microbiology Reviews, 18(2), 383–416. http://doi.org/10.1128/CMR.18.2.383-416.2005

67.CDC Disease Info melioidosis

68.Withers MR (ed.) (2014). USAMRIID's Medical Management of Biological Casualties Handbook (PDF) (8th ed.). Fort Detrick, Maryland: U.S. Army Medical Institute of Infectious Diseases. p. 53.

69.V Vuddhakul; et al. (1999). "Epidemiology of Burkholderia pseudomallei in Thailand". American Journal of Tropical Medicine and Hygiene. 60 (3): 458–461.

70.Wuthiekanun V, Mayxay M, Chierakul W, Phetsouvanh R, Cheng AC, White NJ, Day NP, Peacock SJ (2005). "Detection of Burkholderia pseudomallei in soil within the Lao People's Democratic Republic". Journal of Clinical Microbiology. 43 (2): 923–924. doi:10.1128/JCM.43.2.923-924.2005. PMC 548109  . PMID 15695707.

71.Rattanavong S, Wuthiekanun V, Langla S, Amornchai P, Sirisouk J, Phetsouvanh R, Moore CE, Peacock SJ, Buisson Y, Newton PN (2010). "Randomized Soil Survey of the Distribution of Burkholderia pseudomallei in Rice Fields in Laos". Applied and Environmental Microbiology. 77 (2): 532–536. doi:10.1128/AEM.01822-10. PMC 3020526  . PMID 21075883.

72.Vongphayloth K, Rattanavong S, Moore CE, Phetsouvanh R, Wuthiekanun V, Sengdouangphachanh A, Phouminh P, Newton PN, Buisson Y (2012). "Burkholderia pseudomallei detection in surface water in southern Laos using Moore's swabs". American Journal of Tropical Medicine and Hygiene. 86 (5): 872–877. doi:10.4269/ajtmh.2012.11-0739. PMC 3335696  . PMID 22556090.

73.Lo TJ, Ang LW, James L, Goh KT (2009). "Melioidosis in a Tropical City State, Singapore". Emerging Infectious Diseases. 15 (10): 1645–1647. doi:10.3201/eid1510.090246. PMC 2866399  . PMID 19861063.

74.Kadir KA, Satyavani M, Pande K (2014). "Melioidosis: Antibiogram of cases in Brunei Darussalam" (PDF). Brunei International Medical Journal. 10 (1): 19–24.

75.Yang S (2000). "Melioidosis research in China". Acta Tropica. 77 (2): 157–165. doi:10.1016/S0001-706X(00)00139-X.

76.Ko, WC; Cheung, BM; Tang, HJ; Shih, HI; Lau, YJ; Wang, LR; Chuang, YC (2007). "Melioidosis Outbreak after Typhoon, Southern Taiwan". Emerging Infectious Diseases. 13 (6): 896–898. doi:10.3201/eid1306.060646. PMC 2792857  . PMID 17553230.

77.Chen YS, Lin HH, Mu JJ, Chiang CS, Chen CH, Buu LM, Lin YE, Chen YL (2010). "Distribution of Melioidosis Cases and Viable Burkholderia pseudomallei in Soil: Evidence for Emerging Melioidosis in Taiwan". Journal of Clinical Microbiology. 48 (4): 1432–1434. doi:10.1128/JCM.01720-09. PMC 2849618  . PMID 20147639.

78.Cheng AC, Currie BJ (2005). "Melioidosis: Epidemiology, Pathophysiology, and Management". Clinical Microbiology Reviews. 18 (2): 383–416. doi:10.1128/CMR.18.2.383-416.2005. PMC 1082802  . PMID 15831829.

79.http://www.abc.net.au/news/2017-01-09/melioidosis-risk-spreads-to-central-australia-heavy-rain/8169824

80.Chong VH (2010). "Changing spectrum of microbiology of liver abscess: Now Klebsiella, next Burkholderia pseudomallei". Journal of Emerging Medicine. 41 (6): 676–677. doi:10.1016/j.jemermed.2009.10.027. PMID 20079999.

81.Chugh TD (2008). "Emerging and re-emerging bacterial diseases in India". Journal of Bioscience. 33 (4): 549–555. doi:10.1007/s12038-008-0073-0. PMID 19208980.

82.Antony B, Pinto H, Dias M, Shetty AK, Scaria B, Kuruvilla T, Boloor R (2010). "Spectrum of melioidosis in the suburbs of Mangalore, S West Coast of India". Southeast Asian J Trop Med Public Health. 41 (1): 169–74.

83.Vidyalakshmi K, Chakrapani M, Shrikala B, Damodar S, Lipika S, Vishal S (2008). "Tuberculosis mimicked by melioidosis". International Journal of Tuberculosis and Lung Disease. 12 (10): 1209–1215.

84.Prakash A, Thavaselvam D, Kumar A et al. (2014). "Isolation, identification and characterization of Burkholderia pseudomallei from soil of coastal region of India". Springerplus. 3: 438. doi:10.1186/2193-1801-3-438. PMC4152474  . PMID25187882.

85.Inglis TJ, Rolim DB, De Queroz Sousa A (2006). "Melioidosis in the Americas". American Journal of Tropical Medicine and Hygiene. 75 (5): 947–954. PMID 17123994.

86.O'Sullivan BP, Torres B, Conidi G, et al. (2011). "Burkholderia pseudomallei infection in a child with cystic fibrosis: acquisition in the western hemisphere". Chest. 140 (1): 239–242. doi:10.1378/chest.10-3336. PMID 21729895.

87.Brilhante RS, Bandeira TJ, Cordeiro RA, et al. (2012). "Clinical-epidemiological features of 13 cases of melioidosis in Brazil". Journal of Clinical Microbiology. 50 (10): 3349–3352. doi:10.1128/JCM.01577-12. PMID 22814457.

88.Katangwe T, Purcell J, Bar-Zeev N, Denis B, Montgomery J, Alaerts M, Heyderman RS, Dance DA, Kennedy N, Feasey N, Moxon CA (2013). "Human melioidosis, Malawi, 2011". Emerging Infectious Diseases. 19 (6): 981–984. doi:10.3201/eid1906.120717. PMC 3713813  . PMID 23735189.

89.Morosini MI, Quereda C, Gil H, Anda P, Núñez-Murga M, Cantón R, López-Vélez R (2013). "Melioidosis in traveler from Africa to Spain". Emerging Infectious Diseases. 19 (10): 1656–1659. doi:10.3201/eid1910.121785. PMC 3810733  . PMID 24047798.

90.Struelens MJ, Mondol G, Bennish M, Dance DA (1998). "Melioidosis in Bangladesh: a case report". Transactions of the Royal Society of Tropical Medicine and Hygiene. 82 (5): 777–778. doi:10.1016/0035-9203(88)90234-9.

91.Hosen, Akram (30 Jul 2013). "Deadly bacteria in Gozipur soil". The Daily Star. Dhaka, Bangladesh. Archived from the original o­n 2013-07-21. Retrieved 30 Aug 2013.

92.Dance DA, Smith MD, Aucken HM, Pitt TL (1999). "Imported melioidosis in England and Wales". Lancet. 353 (9148): 208. doi:10.1016/S0140-6736(05)77217-2. PMID 9923882.

93."Burkholderia pseudomallei" (PDF). Mahout Microbiology Review. 7: 4. 2013. Retrieved 24 April 2016.

94.Limmathurotsakul, Direk; Golding, Nick; Dance, David A. B.; Messina, Jane P.; Pigott, David M.; Moyes, Catherine L.; Rolim, Dionne B.; Bertherat, Eric; Day, Nicholas P. J.; Peacock, Sharon J.; Hay, Simon I. (11 January 2016). "Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis". Nature Microbiology. 1 (1): 15008. doi:10.1038/nmicrobiol.2015.8. PMC 4746747  . PMID 26877885.

95.Limmathurotsakul D, Wongratanacheewin S, Teerawattanasook N (2010). "Increasing Incidence of Human Melioidosis in Northeast Thailand". American Journal of Tropical Medicine and Hygiene. 82 (6): 1113–1117. doi:10.4269/ajtmh.2010.10-0038. PMC 2877420  . PMID 20519609.

96.Kanaphun P, Thirawattanasuk N, Suputtamongkol Y, et al. (1993). "Serology and carriage of Pseudomonas pseudomallei: a prospective study in 1000 hospitalized children in northeast Thailand". Journal of Infectious Diseases. 167 (1): 230–233. doi:10.1093/infdis/167.1.230. PMID 7678106.

97.Vuddhakul V, Tharavichitkul P, Na-Ngam N, et al. (March 1999). "Epidemiology of Burkholderia pseudomallei in Thailand". American Journal of Tropical Medicine and Hygiene. 60 (3): 4584–61. PMID 10466977.

98.Kanai K, Dejsirilert S (August 1988). "Pseudomonas pseudomallei and melioidosis, with special reference to the status in Thailand". Japanese Journal of Medical Science and Biology. 41 (4): 123–157. doi:10.7883/yoken1952.41.123. PMID 3075004.

99.Yang S, Tong S, Mo C, et al. (1998). "Prevalence of human melioidosis o­n Hainan Island in China". Microbiology and Immunology. 42 (9): 651–654. doi:10.1111/j.1348-0421.1998.tb02335.x. PMID 9802565.

100.Chen YS, Chen SC, Wu TR, Kao CM, Chen YL (October 2004). "Seroprevalence of anti-flagellin antibody against Burkholderia pseudomallei in Taiwan". Japanese Journal of Infectious Diseases. 57 (5): 224–225. PMID 15507783.

101.Parkes, Helen M.; Shilton, Catherine M.; Jerrett, Ian V.; Benedict, Suresh; Spratt, Brian G.; Godoy, Daniel; O'Brien, Carolyn R.; Krockenberger, Mark B.; et al. (2009). "Primary ocular melioidosis due to a single genotype of Burkholderia pseudomallei in two cats from Arnhem Land in the Northern Territory of Australia". Journal of Feline Medicine and Surgery. 11 (10): 856–863. doi:10.1016/j.jfms.2009.02.009. PMID 19428280.

102.Sprague LD, Neubauer H (2004). "Melioidosis in Animals: A review o­n epizootiology, diagnosis and clinical presentation". Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health. 51 (7): 305–320. doi:10.1111/j.1439-0450.2004.00797.x. PMID15525357.

103.Mollaret HH (1988). ""L'affaire du Jardin des plantes" ou comment le mélioïdose fit son apparition en France". Médecine et Maladies Infectieuses. 18 (Suppl 4): 643–654. doi:10.1016/S0399-077X(88)80175-6.

104.Corkeron ML, Norton R, Nelson PN (2010). "Spatial analysis of melioidosis distribution in a suburban area". Epidemiology and Infection. 138 (9): 1346–1352. doi:10.1017/S0950268809991634. PMID 20092666.

105.Chantratita N, Wuthiekanun V, Limmathurotsakul D, et al. (2008). Currie B, ed. "Genetic Diversity and Microevolution of Burkholderia pseudomallei in the Environment". PLoS Neglected Tropical Diseases. 2 (2): e182. doi:10.1371/journal.pntd.0000182. PMC 2254201  . PMID 18299706.

106.Lin HH; Chen YS; Li YC; e al. (2011). "Burkholderia multivorans acts as an antagonist against the growth of Burkholderia pseudomallei in soil". Microbiology and Immunology. 55 (9): 616–624. doi:10.1111/j.1348-0421.2011.00365.x. PMID 21752084.

107.Inglis TJ, Garrow SC, Henderson M, Clair A, Sampson J, O'Reilly L, Cameron B (2000). "Burkholderia pseudomallei traced to water treatment plant in Australia". Emerging Infectious Diseases. 6 (1): 56–559. doi:10.3201/eid0601.000110. PMC 2627980  . PMID 10653571.

108.Apisarnthanarak A, Khawcharoenporn T, Mundy LM (2012). "Flood-associated melioidosis in a non-endemic region of Thailand". International Journal of Infectious Diseases. 16 (5): e409-410. doi:10.1016/j.ijid.2012.01.013. PMID 22421023.

109.Chierakul W, Winothai W, Wattanawaitunechai C, et al. (2005). "Melioidosis in 6 tsunami survivors in southern Thailand". Clinical Infectious Diseases. 41 (7): 982–990. doi:10.1086/432942. PMID 16142663.

110.Ko WC, Cheung BM, Tang HJ, Shih HI, Lau YJ, Wang LR, Chuang YC (2007). "Melioidosis outbreak after typhoon, southern Taiwan". Emerging Infectious Diseases. 13 (6): 896–898. doi:10.3201/eid1306.060646. PMC 2792857  . PMID 17553230.

111.Inglis TJ, O'Reilly L, Merritt AJ, Levy A, Heath CH (2011). "The aftermath of the Western Australian melioidosis outbreak". American Journal of Tropical Medicine and Hygiene. 84 (6): 851–857. doi:10.4269/ajtmh.2011.10-0480. PMID 21633018.

112.Baker A, Pearson T, Price EP, et al. (2011). "Molecular Phylogeny of Burkholderia pseudomallei from a Remote Region of Papua New Guinea". PLoS o­nE. 6 (3): e18343. doi:10.1371/journal.pone.0018343. PMC 3069084  . PMID 21483841.

113.Suputtamongkol Y, Chaowagul W, Chetchotisakd P, et al. (1999). "Risk factors for melioiosis and bacteremic melioidosis". Clinical Infectious Diseases. 29 (2): 408–413. doi:10.1086/520223. PMID10476750.

114.Phe T, Vlieghe E, Reid T, et al. (2013). "Does HIV status affect the aetiology, bacterial resistance patterns and recommended empiric antibiotic treatment in adult patients with bloodstream infection in Cambodia?". Tropical Medicine and International Health. 18 (4): 485–494. doi:10.1111/tmi.12060. PMID 23294446.

115.Kanai K, Kurata T, Akksilp S, et al. (1992). "A preliminary survey for human immunodeficient virus (HIV) infections in tuberculosis and melioidosis patients in Ubon Ratchathani, Thailand". Japanese Journal of Medical Science and Biology. 45 (5–6): 247–253. doi:10.7883/yoken1952.45.247. PMID 1306871.

116.Chierakul W, Wuthiekanun V, Chaowagul W, et al. (2005). "Short report: disease severity and outcome of melioidosis in HIV coinfected individuals". American Journal of Tropical Medicine and Hygiene. 73 (6): 1165–1166. PMID 16354832.

117.Suputtamongkol Y, Hall AJ, Dance DA, et al. (1994). "The epidemiology of melioidosis in Ubon Ratchatani, Northeast Thailand". International Journal of Epidemiology. 23 (5): 1082–1089. doi:10.1093/ije/23.5.1082. PMID 7860160.

118.Currie BJ, Jacups SP (December 2003). "Intensity of Rainfall and Severity of Melioidosis, Australia". Emerging Infectious Diseases. 9 (12): 1538–1542. doi:10.3201/eid0912.020750. PMC 3034332  . PMID 14720392.

119.Liu Y, Loh JP, Aw LT, Yap EP, Lee MA, Ooi EE (2006). "Rapid molecular typing of Burkholderia pseudomallei, isolated in an outbreak of melioidosis in Singapore in 2004, based o­n variable-number tandem repeats". Transactions of the Royal Society of Tropical Medicine and Hygiene. 100 (7): 687–692. doi:10.1016/j.trstmh.2005.08.017. PMID 16343569.

120.Sam IC, Puthucheary SD (2007). "Melioidosis and rainfall in Kuala Lumpur, Malaysia". Journal of Infection. 54 (5): 519–520. doi:10.1016/j.jinf.2006.07.007. PMID 16965821.

121.Baker, Anthony L.; Ezzahir, Jessica; Gardiner, Christopher; Shipton, Warren; Warner, Jeffrey M.; Wooten, R. Mark (23 September 2015). "Environmental Attributes Influencing the Distribution of Burkholderia pseudomallei in Northern Australia". PLOS o­nE. 10 (9): e0138953. doi:10.1371/journal.pone.0138953. PMC 4580599  . PMID 26398904.

122.Whitmore, A; Krishnaswami, CS (1912). "An account of the discovery of a hitherto undescribed infectious disease among the population of Rangoon". Indian Medical Gazette. 47: 262–267.

123.Strong, Richard P (1944). Stitt's Diagnosis, Prevention and Treatment of Tropical Diseases (7th ed.). Philadelphia: The Blakiston Company. p. 732.

124.Vora SK (February 2002). "Sherlock Holmes and a biological weapon". Journal of the Royal Society of Medicine. 95 (2): 101–103. doi:10.1258/jrsm.95.2.101. PMC 1279324  . PMID 11823558.

125.Whitmore A, Krishnaswami CS (1912). "An account of the discovery of a hitherto undescribed infective disease occurring among the population of Rangoon". Indian Medical Gazette. 92: 262–267.

126.Barker A (19 June 2005). "Rise in melioidosis rates in NT". Australian Broadcasting Corporation. Retrieved 2007-06-24.

127.Orellana C (November 2004). "Melioidosis strikes Singapore". Lancet Infect Dis. 4 (11): 655. doi:10.1016/S1473-3099(04)01190-9. PMID 15534940.

128.C S Krishnaswami. "Morphia injectors' septicaemia". Indian Medical Gazette. 52 (1917): 296–299.

129.Abbink, F. C., J. M. Orendi, and A. J. de Beaufort. 2001. Mother-to-child transmission of Burkholderia pseudomallei. N. Engl. J. Med. 344:1171-1172. [PubMed]

130.Acute Respiratory Distress Syndrome Network. 2000. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N. Engl. J. Med. 342:1301-1308. [PubMed]

131.Ahmed, K., H. D. Enciso, H. Masaki, M. Tao, A. Omori, P. Tharavichikul, and T. Nagatake. 1999. Attachment of Burkholderia pseudomallei to pharyngeal epithelial cells: a highly pathogenic bacteria with low attachment ability. Am. J. Trop. Med. Hyg. 60:90-93. [PubMed]

132.Alejandria, M. M., M. A. Lansang, L. F. Dans, and J. B. Mantaring. 2001. Intravenous immunoglobulin for treating sepsis and septic shock (Cochrane Review). Cochrane Database Syst. Rev. 2:CD001090. [PubMed]

133.Alibek, K. 1998. Statement by Dr. Kenneth Alibek. Terrorist and intelligence operations: potential impact o­n the U.S. economy. Joint Economic Committee, U.S. Congress, Washington, D.C.

134.Alibek, K. 1999. Biohazard. Random House, New York, N.Y.

135.Angus, B. J., M. D. Smith, Y. Suputtamongkol, H. Mattie, A. L. Walsh, V. Wuthiekanun, W. Chaowagul, and N. J. White. 2000. Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis. Br. J. Clin. Pharmacol. 50:184-191. [PMC free article] [PubMed]

136.Annane, D., V. Sebille, C. Charpentier, P. E. Bollaert, B. Francois, J. M. Korach, G. Capellier, Y. Cohen, E. Azoulay, G. Troche, P. Chaumet-Riffaut, and E. Bellissant.2002. Effect of treatment with low doses of hydrocortisone and fludrocortisone o­n mortality in patients with septic shock. JAMA 288:862-871. [PubMed]

137.Anonymous. 1992. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 40-1992. A 43-year-old Cambodian man with several years of recurrent bouts of fever and abdominal pain. N. Engl. J. Med. 327:1081-1087.

138.Anuntagool, A., P. Intachote, P. Naigowit, and S. Sirisinha. 1996. Rapid antigen detection assay for identification of Burkholderia (Pseudomonas) pseudomallei infection. J. Clin. Microbiol. 34:975-976. [PMC free article] [PubMed]

139.Anuntagool, N., P. Aramsri, T. Panichakul, V. R. Wuthiekanun, R. Kinoshita, N. J. White, and S. Sirisinha. 2000. Antigenic heterogeneity of lipopolysaccharide among Burkholderia pseudomallei clinical isolates. Southeast Asian J. Trop. Med. Public Health 31:146-152.

140.Anuntagool, N., P. Intachote, V. Wuthiekanun, N. J. White, and S. Sirisinha. 1998. Lipopolysaccharide from nonvirulent Ara+ Burkholderia pseudomallei isolates is immunologically indistinguishable from lipopolysaccharide from virulent Ara− clinical isolates. Clin. Diagn. Lab. Immunol. 5:225-229. [PMC free article] [PubMed]

141.Anuntagool, N., P. Naigowit, V. Petkanchanapong, P. Aramsri, T. Panichakul, and S. Sirisinha. 2000. Monoclonal antibody-based rapid identification of Burkholderia pseudomallei in blood culture fluid from patients with community-acquired septicaemia. J. Med. Microbiol. 49:1075-1078. [PubMed]

142.Anuntagool, N., P. Rugdech, and S. Sirisinha. 1993. Identification of specific antigens of Pseudomonas pseudomallei and evaluation of their efficacies for diagnosis of melioidosis. J. Clin. Microbiol. 31:1232-1236. [PMC free article] [PubMed]

143.Appassakij, H., K. R. Silpapojakul, R. Wansit, and M. Pornpatkul. 1990. Diagnostic value of the indirect hemagglutination test for melioidosis in an endemic area. Am. J. Trop. Med. Hyg. 42:248-253. [PubMed]

144.Arakawa, M., T. Mitsui, R. Miki, and E. Yabuuchi. 1993. Chronic melioidosis: a report of the first case in Japan. Kansenshogaku Zasshi 67:154-162. [PubMed]

145.Ashdown, L. R. 1979. An improved screening technique for isolation of Pseudomonas pseudomallei from clinical specimens. Pathology 11:293-297. [PubMed]

146.Ashdown, L. R. 1988. In vitro activities of the newer β-lactam and quinolone antimicrobial agents against Pseudomonas pseudomallei. Antimicrob. Agents Chemother. 32:1435-1436. [PMC free article] [PubMed]

147.Ashdown, L. R. 1987. Indirect haemagglutination test for melioidosis. Med. J. Aust. 147:364-365. [PubMed]

148.Ashdown, L. R. 1992. Melioidosis and safety in the clinical laboratory. J. Hosp. Infect. 21:301-306. [PubMed]

149.Ashdown, L. R. 1981. Relationship and significance of specific immunoglobulin M antibody response in clinical and subclinical melioidosis. J. Clin. Microbiol. 14:361-364. [PMC free article] [PubMed]

150.Ashdown, L. R. 1992. Serial serum C-reactive protein levels as an aid to the management of melioidosis. Am. J. Trop. Med. Hyg. 46:151-157. [PubMed]

151.Ashdown, L. R., and R. J. Frettingham. 1984. In vitro activity of various cephalosporins against Pseudomonas pseudomallei. J. Infect. Dis. 150:779-780. [PubMed]

152.Ashdown, L. R., and R. W. Guard. 1984. The prevalence of human melioidosis in Northern Queensland. Am. J. Trop. Med. Hyg. 33:474-478. [PubMed]

153.Ashdown, L. R., R. W. Johnson, J. M. Koehler, and C. A. Cooney. 1989. Enzyme-linked immunosorbent assay for the diagnosis of clinical and subclinical melioidosis. J. Infect. Dis. 160:253-260. [PubMed]

154.Ashdown, L. R., and J. M. Koehler. 1990. Production of hemolysin and other extracellular enzymes by clinical isolates of Pseudomonas pseudomallei. J. Clin. Microbiol. 28:2331-2334. [PMC free article] [PubMed]

155.Astry, C. L., G. A. Warr, and G. J. Jakab. 1983. Impairment of polymorphonuclear leukocyte immigration as a mechanism of alcohol-induced suppression of pulmonary antibacterial defenses. Am. Rev. Respir Dis. 128:113-117. [PubMed]

156.Atkins, T., R. G. Prior, K. Mack, P. Russell, M. Nelson, P. C. Oyston, G. Dougan, and R. W. Titball. 2002. A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis. Infect. Immun. 70:5290-5294. [PMC free article] [PubMed]

157.Badsha, H., C. J. Edwards, and H. H. Chng. 2001. Melioidosis in systemic lupus erythematosus: the importance of early diagnosis and treatment in patients from endemic areas. Lupus 10:821-823. [PubMed]

158.Bagdade, J. D., K. L. Nielson, and R. J. Bulger. 1972. Reversible abnormalities in phagocytic function in poorly controlled diabetic patients. Am. J. Med. Sci. 263:451-456. [PubMed]

159.Bagdade, J. D., R. K. Root, and R. J. Bulger. 1974. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes 23:9-15. [PubMed]

160.Bagdade, J. D., M. Stewart, and E. Walters. 1978. Impaired granulocyte adherence. A reversible defect in host defense in patients with poorly controlled diabetes. Diabetes 27:677-681. [PubMed]

161.Barnes, D. J., T. Gottlieb, S. Naraqi, and R. Benn. 1991. The role of viruses and atypical organisms in the pathogenesis of adult pneumonia in Papua New Guinea. Papua New Guinea Med. J. 34:13-16. [PubMed]

162.Barnes, J. L., J. Warner, W. Melrose, D. Durrheim, R. Speare, J. C. Reeder, and N. Ketheesan. 2004. Adaptive immunity in melioidosis: a possible role for T cells in determining outcome of infection with Burkholderia pseudomallei. Clin. Immunol. 113:22-28. [PubMed]

163.Barnes, P. F., M. D. Appleman, and M. M. Cosgrove. 1986. A case of melioidosis originating in North America. Am. Rev. Respir. Dis. 134:170-171. [PubMed]

164.Bassett, D. C. 1971. The sensitivity of Pseudomonas pseudomallei to trimethoprim and sulphamethoxazole in vitro. J. Clin. Pathol. 24:798-800. [PMC free article] [PubMed]

165.Baumann, B. B., and E. T. Morita. 1967. Systemic melioidosis presenting as myocardial infarct. Ann. Intern. Med. 67:836-842. [PubMed]

166.Beamer, P. R., P. L. Varney, W. G. Brown, F. McDowell, and B. Eck. 1948. Melioidosis. Report of second case from the Western Hemisphere, with bacteriologic studies o­n both cases. Am. J. Pathol. 24:717-718. [PubMed]

167.Beeker, A., K. D. Van de Stadt, and K. Bakker. 1999. Melioidosis. Neth. J. Med. 54:76-79. [PubMed]

168.Ben, R. J., Y. Y. Tsai, J. C. Chen, and N. H. Feng. 2004. Non-septicemic Burkholderia pseudomallei liver abscess in a young man. J. Microbiol. Immunol. Infect. 37:254-257. [PubMed]

169.Berger, S. 2004. 10 April 2004, posting date. Background information o­n melioidosis in Singapore. Gideon o­nline. ProMED-mail 20040411.0986. [Online.]

170.Bernard, G., J. Vincent, P. Laterre, S. LaRosa, J. Dhainaut, A. Lopez-Rodriguez, J. Steingrub, G. Garber, J. Helterbrand, E. Ely, C. J. Fisher, et al. 2001. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344:699-709. [PubMed]

171.Bharadwaj, R., A. Kagal, S. K. Deshpandey, S. A. Joshi, P. M. Khare, A. R. Junnarkar, and M. A. Phadke. 1995. Burkholderia pseudomallei and Indian plague-like illness. Lancet 346:975. (Erratum, 346:1172.) [PubMed]

172.Bharadwaj, R., A. Kagal, S. K. Deshpandey, S. A. Joshi, P. M. Khare, A. R. Junnarkar, and M. A. Phadke. 1994. Outbreak of plague-like illness caused by Pseudomonas pseudomallei in Maharashtra, India. Lancet 344:1574. [PubMed]

173.Biegeleisen, J. Z., R. Mosquera, and W. B. Cherry. 1964. A case of human melioidosis: clinical, epidemiological and laboratory findings. Am. J. Trop. Med. Hyg. 13:89-99. [PubMed]

174.Boe, D. M., S. Nelson, P. Zhang, and G. J. Bagby. 2001. Acute ethanol intoxication suppresses lung chemokine production following infection with Streptococcus pneumoniae. J. Infect. Dis. 184:1134-1142. [PubMed]

175.Brayton, R. G., P. E. Stokes, M. S. Schwartz, and D. B. Louria. 1970. Effect of alcohol and various diseases o­n leukocyte mobilization, phagocytosis and intracellular bacterial killing. N. Engl. J. Med. 282:123-128. [PubMed]

176.Breitbach, K., K. Rottner, S. Klocke, M. Rohde, A. Jenzora, J. Wehland, and I. Steinmetz. 2003. Actin-based motility of Burkholderia pseudomallei involves the Arp 2/3 complex, but not N-WASP and Ena/VASP proteins. Cell Microbiol. 5:385-393. [PubMed]

177.Bremmelgaard, A., I. Bygbjerg, and N. Hoiby. 1982. Microbiological and immunological studies in a case of human melioidosis diagnosed in Denmark. Scand. J. Infect. Dis. 14:271-275. [PubMed]

178.Brett, P. J., D. DeShazer, and D. E. Woods. 1998. Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species. Int. J. Syst. Bacteriol. 48:317-320. [PubMed]

179.Brett, P. J., D. Deshazer, and D. E. Woods. 1997. Characterization of Burkholderia pseudomallei and Burkholderia pseudomallei-like strains. Epidemiol. Infect. 118:137-148. [PMC free article] [PubMed]

180.Brett, P. J., D. C. Mah, and D. E. Woods. 1994. Isolation and characterization of Pseudomonas pseudomallei flagellin proteins. Infect. Immun. 62:1914-1919. [PMC free article] [PubMed]

181.Brett, P. J., and D. E. Woods. 2000. Pathogenesis of and immunity to melioidosis. Acta Trop. 74:201-210. [PubMed]

182.Brett, P. J., and D. E. Woods. 1996. Structural and immunological characterization of Burkholderia pseudomallei O-polysaccharide-flagellin protein conjugates. Infect. Immun. 64:2824-2828. [PMC free article] [PubMed]

183.Brill, D. R., and J. D. Shoop. 1977. Sensitivity of radionuclide isotope brain scan in cerebral melioidosis: case report. J. Nucl. Med. 18:987-989. [PubMed]

184.Bromwich, A. F., and J. C. Hargrave. 1969. Melioidosis in an Australian aboriginal with lepromatous leprosy. Med. J. Aust. 1:638-639. [PubMed]

185.Brook, A. D., T. S. Ahrens, R. Schaiff, D. Prentice, G. Sherman, W. Shannon, and M. H. Kollef. 1999. Effect of a nursing-implemented sedation protocol o­n the duration of mechanical ventilation. Crit. Care Med. 27:2609-2615. [PubMed]

186.Brook, M. D., B. Currie, and P. M. Desmarchelier. 1997. Isolation and identification of Burkholderia pseudomallei from soil using selective culture techniques and the polymerase chain reaction. J. Appl. Microbiol. 82:589-596. [PubMed]

187.Brown, A. E., D. A. Dance, Y. Suputtamongkol, W. Chaowagul, S. Kongchareon, H. K. Webster, and N. J. White. 1991. Immune cell activation in melioidosis: increased serum levels of interferon-gamma and soluble interleukin-2 receptors without change in soluble CD8 protein. J. Infect. Dis. 163:1145-1148. [PubMed]

188.Brown, N. F., J. A. Boddey, C. P. Flegg, and I. R. Beacham. 2002. Adherence of Burkholderia pseudomallei cells to cultured human epithelial cell lines is regulated by growth temperature. Infect. Immun. 70:974-980. [PMC free article] [PubMed]

189.Brown, N. F., A. E. Lew, and I. R. Beacham. 2000. Identification of new transposable genetic elements in Burkholderia pseudomallei using subtractive hybridisation. FEMS Microbiol. Lett. 183:73-79. [PubMed]

190.Brundage, W. G., C. J. J. Thuss, and D. C. Walden. 1968. Four fatal cases of melioidosis in U. S. soldiers in Vietnam. Bacteriologic and pathologic characteristics. Am. J. Trop. Med. Hyg. 17:183-191. [PubMed]

191.Bryan, L. E., S. Wong, D. E. Woods, D. A. B. Dance, and W. Chaowagul. 1994. Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei. Can. J. Infect. Dis. 5:170-178. [PMC free article] [PubMed]

192.Burtnick, M., A. Bolton, P. Brett, D. Watanabe, and D. Woods. 2001. Identification of the acid phosphatase (acpA) gene homologues in pathogenic and non-pathogenic Burkholderia spp. facilitates TnphoA mutagenesis. Microbiology 147:111-120. [PubMed]

193.Carlson, P., and M. Seppanen. 2000. Melioidosis presenting as urinary tract infection in a previously healthy tourist. Scand. J. Infect. Dis. 32:92-93. [PubMed]

194.Chadwick, D. R., B. Ang, Y. Y. Sitoh, and C. C. Lee. 2002. Cerebral melioidosis in Singapore: a review of five cases. Trans. R. Soc. Trop. Med. Hyg. 96:72-76. [PubMed]

195.Chambon, L. 1955. Isolement du bacille de Whitmore a partir du milieu exterieur. Ann. Inst. Pasteur 89:229-235. [PubMed]

196.Chan, C. K., R. H. Hyland, W. D. Leers, M. A. Hutcheon, and D. Chang. 1984. Pleuropulmonary melioidosis in a Cambodian refugee. Can. Med. Assoc. J. 131:1365-1367. [PMC free article] [PubMed]

197.Chan, K., J. Raghuram, J. Low, and A. Kurup. 2003. Epidemiologic characteristics and prognostic determinants of death in severe melioidosis requiring intensive care. Crit. Care Med. 31:A120.

198.Chaowagul, W., A. J. Simpson, Y. Suputtamongkol, M. D. Smith, B. J. Angus, and N. J. White. 1999. A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis. Clin. Infect. Dis. 29:375-380. [PubMed]

199.Chaowagul, W., A. J. Simpson, Y. Suputtamongkol, and N. J. White. 1999. Empirical cephalosporin treatment of melioidosis. Clin. Infect. Dis. 28:1328. [PubMed]

200.Chaowagul, W., Y. Suputtamongkol, D. A. Dance, A. Rajchanuvong, J. Pattara-Arechachai, and N. J. White. 1993. Relapse in melioidosis: incidence and risk factors. J. Infect. Dis. 168:1181-1185. [PubMed]

201.Chaowagul, W., Y. Suputtamongkol, M. D. Smith, and N. J. White. 1997. Oral fluoroquinolones in the maintenance treatment of melioidosis. Trans. R. Soc. Trop. Med. Hyg. 91:599-601. [PubMed]

202.Chaowagul, W., N. J. White, D. A. Dance, Y. Wattanagoon, P. Naigowit, T. M. Davis, S. Looareesuwan, and N. Pitakwatchara. 1989. Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J. Infect. Dis. 159:890-899. [PubMed]

203.Charuchaimontri, C., Y. Suputtamongkol, C. Nilakul, W. Chaowagul, P. Chetchotisakd, N. Lertpatanasuwun, S. Intaranongpai, P. J. Brett, and D. E. Woods. 1999. Antilipopolysaccharide II: an antibody protective against fatal melioidosis. Clin. Infect. Dis. 29:813-818. [PubMed]

204.Chau, P. Y., W. S. Ng, Y. K. Leung, and S. Lolekha. 1986. In vitro susceptibility of strains of Pseudomonas pseudomallei isolated in Thailand and Hong Kong to some newer beta-lactam antibiotics and quinolone derivatives. J. Infect. Dis. 153:167-170. [PubMed]

205.Chen, Y. S., S. C. Chen, C. M. Kao, and Y. L. Chen. 2003. Effects of soil pH, temperature and water content o­n the growth of Burkholderia pseudomallei. Folia Microbiol. (Prague) 48:253-256. [PubMed]

206.Cheng, A. C., D. A. Fisher, N. M. Anstey, D. P. Stephens, S. P. Jacups, and B. J. Currie. 2004. Outcomes of patients with melioidosis treated with meropenem. Antimicrob. Agents Chemother. 48:1763-1765. [PMC free article] [PubMed]

207.Cheng, A. C., D. Godoy, M. Mayo, D. Gal, B. G. Spratt, and B. J. Currie. 2004. Isolates of Burkholderia pseudomallei from northern Australia are distinct by multilocus sequence typing, but strain types do not correlate with clinical presentation. J. Clin. Microbiol. 42:5477-5483. [PMC free article] [PubMed]

208.Cheng, A. C., J. N. Hanna, R. Norton, S. L. Hills, J. Davis, V. L. Krause, G. Dowse, T. J. Inglis, and B. J. Currie. 2003. Melioidosis in northern Australia, 2001-02. Commun. Dis. Intell. 27:272-277. [PubMed]

209.Cheng, A. C., S. P. Jacups, N. M. Anstey, and B. J. Currie. 2003. A proposed scoring system for predicting mortality in melioidosis. Trans. R. Soc. Trop. Med. Hyg. 97:577-581. [PubMed]

210.Cheng, A. C., M. J. Mayo, D. Gal, and B. J. Currie. 2003. Chlorination and pH of drinking water do not correlate with rates of melioidosis in the Northern Territory, Australia. Trans. R. Soc. Trop. Med. Hyg. 97:511-512. [PubMed]

211.Cheng, A. C., M. Obrien, S. P. Jacups, N. M. Anstey, and B. J. Currie. 2004. C-reactive protein in the diagnosis of melioidosis. Am. J. Trop. Med. Hyg. 70:580-582. [PubMed]

212.Cheng, A. C., D. P. Stephens, N. M. Anstey, and B. J. Currie. 2004. Adjunctive granulocyte colony-stimulating factor for treatment of septic shock due to melioidosis. Clin. Infect. Dis. 38:32-37. [PubMed]

213.Cheng, A. C., D. P. Stephens, and B. J. Currie. 2003. Granulocyte colony stimulating factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults. Cochrane Database Syst. Rev. CD004400. [PubMed]

214.Chenthamarakshan, V., M. V. Kumutha, J. Vadivelu, and S. D. Puthucheary. 2001. Distribution of immunoglobulin classes and IgG subclasses against a culture filtrate antigen of Burkholderia pseudomallei in melioidosis patients. J. Med. Microbiol. 50:55-61. [PubMed]

215.Cherian, T., P. Raghupathy, and T. J. John. 1995. Plague in India. Lancet 345:258-259. [PubMed]

216.Chetchotisakd, P., W. Chaowagul, P. Mootsikapun, D. Budhsarawong, and B. Thinkamrop. 2001. Maintenance therapy of melioidosis with ciprofloxacin plus azithromycin compared with cotrimoxazole plus doxycycline. Am. J. Trop. Med. Hyg. 64:24-27. [PubMed]

217.Chetchotisakd, P., P. Mootsikapun, S. Anunnatsiri, K. Jirarattanapochai, C. Choonhakarn, A. Chaiprasert, P. N. Ubol, L. J. Wheat, and T. E. Davis. 2000. Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: a previously unrecognized clinical entity. Clin. Infect. Dis. 30:29-34. [PubMed]

218.Chetchotisakd, P., S. Porramatikul, P. Mootsikapun, S. Anunnatsiri, and K. Kean. 2001. Randomized, double-blind, controlled study of cefoperazone-sulbactam plus cotrimoxazole verses ceftazidime plus cotrimoxazole for the treatment of severe melioidosis. Clin. Infect. Dis. 33:29-34. [PubMed]

219.Cheung, T. K., P. L. Ho, P. C. Woo, K. Y. Yuen, and P. Y. Chau. 2002. Cloning and expression of class A beta-lactamase gene blaA(BPS) in Burkholderia pseudomallei. Antimicrob. Agents Chemother. 46:1132-1135. [PMC free article] [PubMed]

220.Chierakul, W., A. Rajanuwong, V. Wuthiekanun, N. Teerawattanasook, M. Gasiprong, A. Simpson, W. Chaowagul, and N. J. White. 2004. The changing pattern of bloodstream infections associated with the rise in HIV prevalence in northeastern Thailand. Trans. R. Soc. Trop. Med. Hyg. 98:678-686. [PubMed]

221.Chodimella, U., W. L. Hoppes, S. Whalen, A. J. Ognibene, and G. W. Rutecki. 1997. Septicemia and suppuration in a Vietnam veteran. Hosp. Pract. 32:219-221. [PubMed]

222.Christenson, B., Z. Fuxench, J. A. Morales, R. A. Suarez-Villamil, and L. M. Souchet.2003. Severe community-acquired pneumonia and sepsis caused by Burkholderia pseudomallei associated with flooding in Puerto Rico. Bol. Asoc. Med. P.R. 95:17-20. [PubMed]

223.Christenson Bravo, B., J. E. Rodriguez, G. Vazquez, and C. H. Ramirez Ronda. 1986. Pseudomonas pseudomallei (melioidosis): acute septicemia and meningitis in patient with systemic lupus erythematosus. Bol. Asoc. Med. P.R. 78:347-349. [PubMed]

224.Chua, K. L., Y. Y. Chan, and Y. H. Gan. 2003. Flagella are virulence determinants of Burkholderia pseudomallei. Infect. Immun. 71:1622-1629. [PMC free article] [PubMed]

225.Clayton, A. J., R. S. Lisella, and D. G. Martin. 1973. Melioidosis: a serological survey in military personnel. Mil. Med. 138:24-26. [PubMed]

226.Clough, A. R., Z. Wang, R. S. Bailie, C. B. Burns, and B. J. Currie. 2003. Case-control study of the association between kava use and pneumonia in eastern Arnhem and Aboriginal communities (Northern Territory, Australia). Epidemiol. Infect. 131:627-635. [PMC free article] [PubMed]

227.Coenye, T., J. J. LiPuma, D. Henry, B. Hoste, K. Vandemeulebroecke, M. Gillis, D. P. Speert, and P. Vandamme. 2001. Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients. Int. J. Syst. Evol. Microbiol. 51:271-279. [PubMed]

228.Corkill, M. M., and B. Cornere. 1987. Melioidosis: a new disease to New Zealand. N.Z. Med. J. 100:106-107. [PubMed]

229.Cottew, G. S. 1950. Melioidosis in sheep in Queensland. A description of the causal organism. Aust. J. Exp. Biol. Med. Sci. 28:677-683. [PubMed]

230.Crotty, J. M., A. F. Bromich, and J. V. Quinn. 1963. Melioidosis in the Northern Territory: a report of two cases. Med. J. Aust. i:274-275. [PubMed].

Các nội dung khác »

---